Plus, news about Genentech, Mestag and BioVie:
📊 Pfizer says next-gen breast cancer drug succeeds in Phase 2: The company is developing a CDK4 inhibitor called atirmociclib as a successor to its breast cancer drug …
The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.
Over a hot pot dinner in Shanghai in the fall of 2024, former I-Mab Biopharma executives Lei Fang and Jielun Zhu began to plot their
Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.
An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.
Biotech’s best-funded AI startup detailed its first AI model on Tuesday, giving a glimpse at what it’s been doing since launching out of stealth nearly
Plus, news about Genentech, Mestag and BioVie:
📊 Pfizer says next-gen breast cancer drug succeeds in Phase 2: The company is developing a CDK4 inhibitor called atirmociclib as a successor to its breast cancer drug …